Remove 2005 Remove Clinical Trials Remove Consumption Remove Medicine
article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

The authors share this view, assessing that the current evidence shows that marijuana can impair driving ability and increase crash risk, especially shortly after consumption. Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005–2017. A meta-analysis by Asbridge et al.

Policy 59
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Does Marijuana Make You Lose Weight?

CannaMD

For instance, in a 2005 review of 297 medical charts, the Journal of Addictive Diseases reported that the rate of cannabis use in the last 12 months was lower in obese subjects than in subjects with a lower BMI. As counterintuitive as it might sound, this conclusion is actually in line with a growing number of studies.

Marijuana 106
article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.